发明名称 Use of an isolated antibody D2E7 for the treatment of a disorder in which TNF(alpha) activity is detrimental
摘要 The use of an isolated antibody D2E7 in the manufacture of a medicament for the treatment of a disorder in which TNFalpha activity is detrimental.
申请公布号 NZ536216(A) 申请公布日期 2006.08.31
申请号 NZ19970536216 申请日期 1997.02.10
申请人 ABBOTT BIOTECHNOLOGY LTD 发明人 SALFELD, JOCHEN G;ALLEN, DEBORAH J;KAYMAKCALAN, ZEHRA;LABKOVSKY, BORIS;MANKOVICH, JOHN A;MCGUINESS, BRIAN T;ROBERTS, ANDREW J;SAKORAFAS, PAUL;HOOGENBOOM, HENDRICUS R J M;SCHOENHAUT, DAVID;VAUGHAN, TRISTAN J;WHITE, MICHAEL;WILTON, ALISON J
分类号 C12N15/09;A61K31/00;A61K31/40;A61K31/403;A61K31/404;A61K31/415;A61K31/4164;A61K31/4178;A61K31/505;A61K31/517;A61K31/52;A61K31/529;A61K31/57;A61K31/573;A61K31/675;A61K38/00;A61K38/04;A61K38/16;A61K39/39;A61K39/395;A61P1/00;A61P1/04;A61P1/16;A61P3/10;A61P7/00;A61P7/04;A61P9/00;A61P9/04;A61P9/10;A61P11/00;A61P11/16;A61P13/12;A61P17/00;A61P17/02;A61P19/02;A61P19/06;A61P25/00;A61P27/02;A61P29/02;A61P31/00;A61P31/04;A61P31/12;A61P31/18;A61P33/06;A61P35/00;A61P35/04;A61P37/00;A61P37/02;A61P37/06;A61P37/08;A61P39/02;C07K16/24;C12N1/21;C12N5/10;C12P21/08;G01N33/53;G01N33/543;G01N33/564;G01N33/576;G01N33/68;(IPC1-7):C12N15/13 主分类号 C12N15/09
代理机构 代理人
主权项
地址
您可能感兴趣的专利